scholarly article | Q13442814 |
P50 | author | Howard E. Gendelman | Q64858836 |
P2093 | author name string | Nan Gong | |
R Lee Mosley | |||
Ashley D Reynolds | |||
Jianuo Liu | |||
Xiuyan Huang | |||
P2860 | cites work | Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis | Q78404404 |
FOXP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients | Q80358011 | ||
HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells | Q24802813 | ||
Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment | Q24814874 | ||
Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 | ||
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses | Q29619908 | ||
Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection | Q30883324 | ||
Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. | Q33265694 | ||
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection | Q33880339 | ||
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis | Q34049376 | ||
Cellular immune response to human immunodeficiency virus | Q34292780 | ||
Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression | Q34311400 | ||
Apo2L/TRAIL and its death and decoy receptors | Q34532325 | ||
CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. | Q34544033 | ||
Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection | Q34571341 | ||
Dementia and neurocognitive disorders due to HIV-1 infection | Q34602429 | ||
Oxidative stress and the pathogenesis of neurodegenerative disorders | Q34659807 | ||
HIV leucoencephalopathy and TNFalpha expression in neurones | Q35488817 | ||
Updated research nosology for HIV-associated neurocognitive disorders | Q35755761 | ||
Human immunodeficiency virus encephalitis in SCID mice. | Q35782070 | ||
HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. | Q35848896 | ||
Simian immunodeficiency virus (SIV) infection influences the level and function of regulatory T cells in SIV-infected rhesus macaques but not SIV-infected sooty mangabeys | Q35857361 | ||
HIV-1 infection and AIDS: consequences for the central nervous system | Q36098879 | ||
Inflammation and neuroaxonal injury in multiple sclerosis and AIDS dementia complex: implications for neuroprotective treatment | Q36247139 | ||
Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases | Q36302045 | ||
Experimental and potential future therapeutic approaches for HIV-1 associated dementia targeting receptors for chemokines, glutamate and erythropoietin | Q36302081 | ||
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status | Q36399748 | ||
Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis | Q36403300 | ||
Treg control of antimicrobial T cell responses | Q36450013 | ||
Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens | Q36954734 | ||
Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers | Q37015519 | ||
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy | Q37066971 | ||
Neurobiology of HIV. | Q37073645 | ||
Depletion of regulatory T cells in HIV infection is associated with immune activation | Q38881101 | ||
The neuropathology of the acquired immune deficiency syndrome (AIDS). A review | Q39644768 | ||
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease | Q40098160 | ||
An experimental model system for HIV-1-induced brain injury | Q40603263 | ||
In vivo modeling of HIV-1 mediated neurodegeneration. | Q41089712 | ||
The neuropathogenesis of the AIDS dementia complex. | Q41694913 | ||
Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. | Q42462823 | ||
Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain | Q42495493 | ||
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis | Q42518980 | ||
Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. | Q42519857 | ||
Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses | Q42947652 | ||
Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis | Q43583436 | ||
Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection | Q43596644 | ||
Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. | Q43717545 | ||
Glucose-responsive expression of the human insulin promoter in HepG2 human hepatoma cells | Q44695816 | ||
Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study | Q44715816 | ||
The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. | Q45304800 | ||
Enrichment and persistence of virus-specific CTL in the brain of simian immunodeficiency virus-infected monkeys is associated with a unique cytokine environment. | Q45405005 | ||
Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome | Q45412296 | ||
Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection | Q45420228 | ||
Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients | Q45609885 | ||
CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis | Q45729143 | ||
The validity of immunological studies in human immunodeficiency virus infection: a three-year follow-up of 235 homo- or bisexual persons | Q45839302 | ||
The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. | Q45853669 | ||
Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy | Q45871925 | ||
Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis | Q46470590 | ||
TNF-alpha-induced optic nerve degeneration and nuclear factor-kappaB p65. | Q46614846 | ||
Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection | Q47926468 | ||
The neuropathology of adult HIV infection. | Q48291701 | ||
HIV-specific lymphoproliferative responses in asymptomatic HIV-infected individuals. | Q52052815 | ||
Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. | Q52932694 | ||
Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. | Q53674954 | ||
Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. | Q54656483 | ||
Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages | Q56794691 | ||
Cell surface markers of regulatory T cells are not associated with increased forkhead box p3 expression in blood CD4+ T cells from HIV-infected patients responding to antiretroviral therapy | Q60343443 | ||
AIDS dementia complex | Q68490162 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV | Q15787 |
neurodegeneration | Q1755122 | ||
murine model | Q122890741 | ||
P304 | page(s) | 3855-3865 | |
P577 | publication date | 2009-03-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration | |
P478 | volume | 182 |
Q37617639 | A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection |
Q90047739 | Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections |
Q35401923 | Blockade of Notch ligand δ1 promotes allograft survival by inhibiting alloreactive Th1 cells and cytotoxic T cell generation |
Q38912920 | Brain Invasion by CD4(+) T Cells Infected with a Transmitted/Founder HIV-1BJZS7 During Acute Stage in Humanized Mice |
Q41215449 | Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis☆ |
Q26827612 | Bridge between neuroimmunity and traumatic brain injury |
Q37228055 | CD 4+ T cells in the pathobiology of neurodegenerative disorders |
Q90675584 | CD4+ Regulatory T Lymphocytes Prevent Impaired Cerebral Blood Flow in Angiotensin II-Induced Hypertension |
Q37411386 | CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease? |
Q33956951 | Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis |
Q38815289 | Cytotoxic CD8+ T cell ablation enhances the capacity of regulatory T cells to delay viral elimination in Theiler's murine encephalomyelitis. |
Q30477752 | Depression and immunity: a role for T cells? |
Q35000860 | Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. |
Q35068792 | Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders |
Q42256730 | Dynamic changes of Foxp3(+) regulatory T cells in spleen and brain of canine distemper virus-infected dogs |
Q37410928 | Enhanced human immunodeficiency virus Type 1 expression and neuropathogenesis in knockout mice lacking Type I interferon responses |
Q35842559 | Foxp3+ regulatory T cells control persistence of viral CNS infection |
Q28741958 | Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy |
Q33721196 | Functional Proteomic Analysis for Regulatory T Cell Surveillance of the HIV-1-Infected Macrophage |
Q33733529 | HIV-1 neuroimmunity in the era of antiretroviral therapy. |
Q26995345 | Homeostasis and function of regulatory T cells in HIV/SIV infection |
Q36832077 | Immune regulation and evasion of Mammalian host cell immunity during viral infection |
Q34388925 | In vitro HIV infection impairs the capacity of myeloid dendritic cells to induce regulatory T cells |
Q37982378 | Inflammation and adaptive immunity in Parkinson's disease |
Q30497868 | Influence of enriched environment on viral encephalitis outcomes: behavioral and neuropathological changes in albino Swiss mice |
Q37762195 | Macrophages in Alzheimer's disease: the blood-borne identity |
Q30624704 | Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain |
Q34345744 | Microglial dysregulation in psychiatric disease |
Q37538776 | NanoART, neuroAIDS and CNS drug delivery |
Q35897923 | Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells |
Q27694728 | Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior |
Q57491949 | Purinergic Profiling of Regulatory T-cells in Patients With Episodic Migraine |
Q39617094 | Regulatory T Cells Diminish HIV Infection in Dendritic Cells - Conventional CD4(+) T Cell Clusters |
Q26995751 | Regulatory T cell in stroke: a new paradigm for immune regulation |
Q30493249 | Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease |
Q35029947 | Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism |
Q37548495 | Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity. |
Q49979151 | Regulatory T cells in retroviral infections |
Q37498880 | Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms |
Q35803957 | Rodent models for HIV-associated neurocognitive disorders. |
Q35041314 | Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study. |
Q36826771 | Shen-Qi-Jie-Yu-Fang exerts effects on a rat model of postpartum depression by regulating inflammatory cytokines and CD4(+)CD25(+) regulatory T cells |
Q99344935 | The delicate balance between neurotoxicity and neuroprotection in the context of HIV-1 infection |
Q38035240 | The role of regulatory T cells in neurodegenerative diseases |
Q41225635 | Three-dimensional morphometric analysis of microglial changes in a mouse model of virus encephalitis: age and environmental influences. |
Search more.